Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1549230 NEW YORK, NY

Position in RARE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,974,439
+$2,974,439 QoQ
Shares Held
141,978
Ownership
0.144%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Derivatives in RARE

reported options exposure · as of Dec 31, 2025
CallValue
$2,500,100
CallShares
108,700
PutValue
$1,552,500
PutShares
67,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $541,089,850 across 142 Biotechnology names. RARE ranks #42 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RARE

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,974,439 141,978
2025-12-31 $1,552,500 67,500
2025-12-31 $2,500,100 108,700
2025-09-30 $1,391,771 46,269
2025-09-30 $992,640 33,000
2025-06-30 $3,926,880 108,000
2025-06-30 $417,921 11,494
2025-06-30 $7,402,896 203,600
2025-03-31 $2,377,367 65,655
2025-03-31 $1,097,163 30,300
2025-03-31 $1,234,761 34,100
2024-12-31 $2,290,921 54,455
2024-09-30 $3,025,586 54,466
2023-09-30 $1,340,119 37,591
2023-06-30 $1,143,747 24,794